Viking Therapeutics
VKTX
#3604
Rank
โ‚ฌ2.45 B
Marketcap
21,84ย โ‚ฌ
Share price
-3.31%
Change (1 day)
-64.09%
Change (1 year)

Revenue for Viking Therapeutics (VKTX)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Viking Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.49 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ66.33 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.55 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA